Avalo Therapeutics (AVTX) Depreciation and Depletion (2014 - 2017)
Avalo Therapeutics (AVTX) posted Depreciation and Depletion of $4906.0 for Q4 2017, down 8.49% on a QoQ basis from $5361.0 in Q3 2017, and down 23.2% year-over-year from $6388.0 in Q4 2016.
Avalo Therapeutics (AVTX) Depreciation and Depletion (2014 - 2017) Analysis & Trends
Avalo Therapeutics' Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $4906.0 for Q4 2017.
- Quarterly Depreciation and Depletion fell 23.2% year-over-year to $4906.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $21956.0 (down 18.25% YoY) and the FY2025 annual result came in at $300000.0, up 50.0% from the prior year.
- Depreciation and Depletion was $4906.0 for Q4 2017 at Avalo Therapeutics, down from $5361.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $7881.0 in Q4 2014 and bottomed at $4906.0 in Q4 2017.
- A 4-year average of $6169.3 and a median of $6148.0 in 2015 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2016 — Depreciation and Depletion increased 22.99% — and 2017, when it decreased 23.98%.
- Avalo Therapeutics' Depreciation and Depletion stood at $7881.0 in 2014, then slipped by 21.99% to $6148.0 in 2015, then climbed by 3.9% to $6388.0 in 2016, then dropped by 23.2% to $4906.0 in 2017.
- Business Quant data shows AVTX's Depreciation and Depletion at $4906.0 in Q4 2017, $5361.0 in Q3 2017, and $5859.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 4,906.00 |
| Dec 31, 2017 | 4,906.00 |
| Sep 30, 2017 | 5,361.00 |
| Sep 30, 2017 | 5,361.00 |
| Jun 30, 2017 | 5,859.00 |
| Jun 30, 2017 | 5,859.00 |
| Mar 31, 2017 | 5,830.00 |
| Mar 31, 2017 | 5,830.00 |
| Dec 31, 2016 | 6,388.00 |
| Dec 31, 2016 | 6,388.00 |
| Sep 30, 2016 | 7,052.00 |
| Sep 30, 2016 | 7,052.00 |
| Jun 30, 2016 | 6,628.00 |
| Jun 30, 2016 | 6,628.00 |
| Mar 31, 2016 | 6,788.00 |
| Mar 31, 2016 | 6,788.00 |
| Dec 31, 2015 | 6,148.00 |
| Dec 31, 2015 | 6,148.00 |
| Sep 30, 2015 | 6,322.00 |
| Sep 30, 2015 | 6,322.00 |